Skip to main content
Fig. 6  | Cancer Nanotechnology

Fig. 6 

From: Designing nanostructured lipid carriers modified with folate-conjugated chitosan for targeted delivery of osthole to HT-29 colon cancer cells: investigation of anticancer, antioxidant, and antibacterial activities

Fig. 6 

Morphological changes of HT-29 cells during a 24-hour treatment plan with 65 and 115 μg/ml of OST-NCF-NPs compared with the untreated group confirmed the presence of apoptotic cells. In the control sample, cells exhibited a healthy, living state. However, the presence of yellow and orange/red cells indicated the occurrence of apoptosis. (N=3, Mean ± SD). OST-NCF- NPs: Nanostructured lipid carriers coated with chitosan-conjugated folate nanoparticles containing Osthole

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us